Bibliography - Disposable Bioprocessing Systems - page 284

Sinclair, A. and Monge, M. 2009. Evaluating disposable mixing systems. Biopharm Int .
22 (2): 24-29.
Sinclair, A. 2009. Biological products manufacturing: Cost challenges and opportuni-
ties now and in the future. BPI, Raleigh, NC, October 12.
Sinclair, A., Leveen et al. 2008. The Environmental Impact of Disposable Technologies,
The Biopharm International Guide, November 2008; Base of the analysis: Typical
mAb process at 3 x 2000 L scale.
Sinclair, A. and Monge, M. 2004. Biomanufacturing for the 21st century: Designing
a concept facility based on single-use systems. BioProcess Int . 2 (Suppl.): 26-31.
Singh, S.K., Kolhe, P., Wang, W., and Nema, S. 2009. Large-scale freezing of biologics:
A practitioner's review, part 1: Fundamental aspects. BioProcess Int . 7 (9): 32-44.
Singh, S.K., Kolhe, P., Wang, W., and Nema, S. 2009. Urge-scale freezing of biologics: A
practitioner's review, part 2: Practical advice. BioProcess Int . 7 (10): 34-42.
Singh, V. 1999. Disposable bioreactor for cell culture using wave-induced motion.
Cytotechnology 30: 149-158.
Singh, V. 2004. Bioprocessing tutorial: Mixing in large disposable containers. Genet.
Eng. Biotechnol. News 24 (3): 42-43.
Singh, V. 2005. The Wave Bioreactor Story . Wave Biotech LLC, Somerset.
Slivac, I., Srček, V.G., Radoševic, K., Kmetič, I., and Kniewald, Z. 2006. Aujeszky's
disease virus production in disposable bioreactors. J. Biosci . 3: 363-368.
Smiley, D., Rhee, M., Ziemer, D., Gallina, D., Phillips, L.S., Kolm, P., and Umpierrez,
G.E. 2005. Lack of follow-up care: A major obstacle to optimal care in Latinos
with diabetes. Diabetes 54: A588-A589.
Smith, M. 2004. An evaluation of Protein A and non-Protein A methods for the
recovery of monoclonal antibodies and considerations for process scale-up.
Scaling-up of Biopharmaceutical Products, The Grand, Amsterdam, January.
Smith, M. 2005. Strategies for the purification of high titer, high volume mamma-
lian cell culture batches. BioProcess International European Conference and
Exhibition, Berlin, April.
Sofer, G. and Lister, D.C. 2003. Inactivation methods grouped by virus: Virus inactiva-
tion in the 1990s and into the 21st century. BioPharm. Int 6: 37-42.
Solle, D., Geissler, D., Stark, E., Scheper, T., and Hitzmann, B. 2003. Chemometric
modelling based on 2D-fluorescence spectra without a calibration measure-
ment. Bioinformatics 19 (2): 173-177.
Song, K.-S., Zhang, G.-J., Nakamura, Y., Furukawa, K., Hiraki, T., Yang, J.-H., Funatsu,
T., Ohdomari, I., and Kawarada, H. 2006. Label-free DNA sensors using ultra-
sensitive diamond field-effect transistors in solution. Phys. Rev. E Stat. Nonlin.
Soft Matter Phys . 74 (4): 041919.
Stärk, E., Hitzmann, B., Schügerl, K., Scheper, T., Fuchs, C., Köster, D., and Märkl,
H. 2002. In-situ-fluorescence-probes: A useful tool for non-invasive bioprocess
monitoring. Adv. Biochem. Eng. Biotechnol . 74: 21-38.
Stein, A. and Kiesewetter, A. 2007. Cation exchange chromatography in antibody puri-
fication: pH screening for optimized binding and HCP removal. J. Chromatogr.
B 848: 151-158.
Stone, T.E., Goel, V., and Leszczak, J. 1994. Methodology for analysis of extractables:
A model stream approach. Pharm. Technol . 18: 116-121.
Streeter, I., Leventis, H.C., Wildgoose, G.G., Pandurangappa, M., Lawrence, N.S.,
Jiang, L., Jones, T.G.J., and Compton, R.G. 2004. A sensitive reagentless pH probe
with a ca. 120 mV/pH unit response. J. Solid State Electrochem . 8 (10): 718-721.